| Lightcalls.com |
|
|
![]() |
Infantile eczema (IE), a original o...Infantile eczema (IE), a original of atopic (hereditarily influenced) eczema, is a skin condition that occasions a red, scaling, thick patch commonly appearing forward the flexor aspects of the arms, leg neck hands and face. The skin rash can be quite itchy, and it drip bloods easily when scratched. It commonly appears between the ages of 1-3 years, admitting it's estimated to affect about 10 percent of children below the age of 5. tangled Problem Case in point, a young mother freshly brought her 16-month-old girl, Brie, to my office with the complaint of morose itching and a skin rash covering 70 percent of her daughter's carcass The rash began mildly enough--just a not many patches on Brie's arms and neck--at around 13 chapss of age. The condition remained about the same, the mother said, for the nearest several months. Then, 2 weeks ago, things became plenteous worse. The child scratched with equal reason much her skin bled, and she had put in commotion sleeping. The mother suspected that heat, excessively scalding;-very warm water and some fabrics made the skin flare up I asked about Brie's diet. Brie had been introduced to solid diets at the age of 12 month although she continued to breastfeed. The main nourishment groups the child ate were grains, simple pods fruits, vegetables, cheese, peanut butter and--rarely--eggs or domestic fowls She drank only water, fruit juices that were half-diluted with water, and soymilk. Diagnoses I betimes diagnosed Brie's condition as infantile atopic eczema. There is a healthy hereditary link between eczema, hay ferment and asthma. Indeed, the mother's medical history showed positive for IE and asthma, while Brie's father's history, indicated seasonal allergies. There are also several biological factors that pretend to be linked to this condition, including fodder allergies, essential fatty acid deficiency, intestinal permeability, climate, emotional stres and vitamin and mineral deficiency. Treatment Goals Our treatment goals for Brie were targeted toward: * Balancing usual nutritional deficiencies associated with IE, including essential fatty acids, bioflavonoids and zinc; * Eliminating possible regimen allergens, the most common of which are bananas, peanuts, soy oranges, dairy, gluten grains and eggs; * Improving gastrointestinal profloras to cut down the allergic load in the body Adjusted Diet and supply Program I immediately insinuateed modifying Brie's diet, using rice milk instead of soy; almond butter and tahini instead of peanut products; and rice, millet or amaranth instead of gluten grains. I also attract favor toed that the mother avoid eating the same sustenances to decrease Brie's exposure between the sides of breast milk. In addition, I started Brie forward the following supplement program: * 1 tablespoon of hemp se oil through day, added to hot cereals, mashed vegetables or pasta; * 1 teaspoon of codfish liver oil per day (there are several different flavors available, including lemon orange and strawberry) to provide omega-3 fatty acids and vitamins A and D which are also important nutrients for skin health; * A Lactobacillus acidophilus and Lactobacillus bifidus mixture consisting of 6 billion taken brace times per day; * A mixed bioflavonoid compage of 200 milligrams (mg), plus 100 mg of vitamin C and 5 mg of zinc in a liquid form taken daily. I further praiseed that the mother give Brie an herbal formula to help her skin heal and to bring inflammation. The formula contained exasperate leaf, violet leaf, wild oat se chamomile flowers, cleavers and fenugreek se added to warm spearmint tea or diluted juice. Topical Treatment Finally, I made these suggestions for topical treatment: * Apply a mixture of almond oil, rosehip se oil and sesame se oil generously to all affected areas of the body; * Avoid overbathing with soaps, and arid the skin well; * Avoid use of baby oils or creams; * Avoid overdressing, using excessively warm water, or exposing the child's skin to direct sunlight; * guard the child's hands with cotton sock or mittens while she be deads to reduce the irritation from nighttime scratching. Results I'm excessively happy to say that Brie answered quite well. At her 1-month respond visit, she had improved about 10 percent overall, with les itching. After a filled 3 months of treatment, she was 80 percent clear of the rash. Internationally known lecturer and author Mary Bove ND exhibits real-life case studies from her clinical practice in Vermont COPYRIGHT 2004 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved |
![]() |
Other Articles
-Morphotek will collaborat...-Eksigent Technologies nam... -The benefits of outsourci... -Sartorius Corporation ... -In our previous column, w... -Efoora appointed Michael ... -Affymax appointed Anne-Ma... -Traditionally, continuous... -New Brunswick Scientific ... -The German-American firm ... -Don G. Burstyn, formerly ... -American patients are mor... -Summary Prior to va... -BioPharm Editorial Adviso... -Australia agreed to spend... -The Biotechnology Industr... -Ambion, The RNA Company i... -Therapies based on living... -A recent survey found tha... -ViroLogic will acquire Ac... -Cardinal Health named Joh... -One of the greatest chall... -As the president of a sma... -Sweden-based Biovitrum wi... -Nanogen appointed David L... -The Experion Process Know... -Although biomedical resea... -The Supreme Court of Cana... -Netherlands-based DSM Bio... -David A. Smoller joined S... -A few months ago, I wrote... -Panacos Pharmaceuticals w... -Karen K. Vaccaro will res... -Acceleron Pharma appointe... -Two quarterly meetings of... -Illinois-based Abbot Labo... -FKI Logistics announced t... -The following corrections... -It its widest definition,... -UK-based Xcellsyz will li... -Andrew P. Aromando joined... -Invitrogen's comprehensiv... -Last month, we described ... -The Swiss life sciences c... -Protein Design Labs (PDL)... -Model It HNMR, the newest... -Tech transfer, like chang... -QLT and Atrix Laboratorie... -Dendreon announced Christ... -Baxter Pharmaceutical Sol... -The biopharmaceutical ind... -GlaxoSmithKline announced... -Montreal-based Caprion Ph... -Xenova Group recently ann... -Cole-Parmer's new 192-pag... -Over the last decade ther... -Benchmark your facility p... -As biotechnology organiza... -Frederick D. Sancillo, fo... -Insmed acquired a recombi... -Baxter Pharmaceutical Sol... -Model It HNMR, the newest... -DA's regulation 21 CFR Pa... -Robert P. Ryan joined Ath... -A new report from Busines... -Biotest offers a complete... -Swagelok offers a brochur... -Partnering is a global ph... -Human Genome Sciences CEO... -Shorten the process devel... -The licensure of biotechn... -Rodger Currie joined Amge... -The GEA Filtration Model ... -A multi-channel chemistry... -From June 6-9, San Franci... -Skanska USA Building Inc.... -New Brunswick Scientific'... -AVI BioPharma appointed P... -Ambion, The RNA Company, ... -"If you want to be a... -Xcellerex appointed Susan... -Researchers identified th... -Cool Spring Business Park... -In October 2003, Shenzhen... -Laureate Pharma appointed... -After a 6-5 vote by Calif... -QSourcing, a service of Q... -The recent discovery of &... -Affymax added Douglas L. ... -USDA recently approved tw... -BioPharm International is... -Serologicals has released... -This document by Shenzhen... -Robert Bronstein joined A... -Gloucester Gains Fujisawa... -With more than 30 years o... -Pall's SUPRAdisc II depth... -In today's competitive ma... -Protein Design Labs repor... -Charles A. Rice will repl... -AstraZeneca's Faslodex (f... |
| . |